Hinge Health (NYSE:HNGE) Now Covered by Analysts at William Blair

William Blair assumed coverage on shares of Hinge Health (NYSE:HNGE) in a research report issued on Monday, Marketbeat reports. The firm set an “outperform” rating on the stock.

A number of other equities research analysts also recently issued reports on HNGE. Truist Financial started coverage on shares of Hinge Health in a research note on Monday. They issued a “buy” rating and a $48.00 price target on the stock. Wall Street Zen upgraded shares of Hinge Health to a “hold” rating in a research note on Monday, June 2nd. Needham & Company LLC initiated coverage on shares of Hinge Health in a research note on Monday. They set a “buy” rating and a $47.00 target price on the stock. Piper Sandler assumed coverage on shares of Hinge Health in a research report on Monday. They issued an “overweight” rating and a $41.00 price objective on the stock. Finally, Bank of America began coverage on shares of Hinge Health in a research report on Monday. They set a “buy” rating and a $42.00 price objective for the company. One equities research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat.com, Hinge Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $46.00.

Hinge Health Stock Down 0.7%

Shares of NYSE HNGE opened at $34.76 on Monday. Hinge Health has a 1 year low of $33.42 and a 1 year high of $43.80.

Hinge Health Company Profile

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.